Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Paula Tanabe, RN, PhD
Researcher Laurel Chadwick Distinguished Professor
Duke University School of Nursing
307 Trent Drive
Durham, North Carolina, United States
Paula Tanabe, PhD, RN, MPH, FAEN, FAAN, is a Professor in the Schools of Nursing and Medicine and health services and clinical researcher. Dr. Tanabe’s program of research focuses on improving systems of healthcare and patient outcomes for persons with sickle cell disease. Dr. Tanabe has a strong focus on improving emergency department care for this population and has conducted many investigations in this area.
Dr. Tanabe currently has AHRQ funding to disseminate decision support tools to primary care and emergency department providers throughout North Carolina and portions of South Carolina. These tools were based upon the National Heart, Lung and Blood Institute evidence-based recommendations for the treatment of sickle cell disease. Dr. Tanabe is also the co-PI for the National Heart, Lung and Blood Institute “Sickle Cell Disease Implementation Consortium, U01”.
Dr. Tanabe has conducted investigations aimed at improving pain management in the emergency department, with a strong focus on patients with sickle cell disease. Dr. Tanabe developed the Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a decision support tool aimed at improving the quality of care provided to adults with sickle cell disease in the ED setting.
Related Content
-
Today’s Faces of Sickle Cell Disease: Tosin OlaDuring a long hospitalization in 2005, T...
-
6th Annual Chicago Sickle Cell SummitDate & Time Sep 28, 2023 11:00 AM...
-
Boston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful CrisesOBJECTIVES: Sickle cell disease is the ...
-
Chavis Patterson, PhDDr. Chavis Patterson is a licensed Clini...
-
Alan W. FlakeDr. Flake is an attending surgeon in the...
-
Risk Factors for 30-Day Readmission in Adults with Sickle Cell DiseaseBACKGROUND: Readmission to the hospital...
+myBinder